These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 16195422

  • 1. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
    Otani T, Yamaguchi K, Scherl E, Du B, Tai HH, Greifer M, Petrovic L, Daikoku T, Dey SK, Subbaramaiah K, Dannenberg AJ.
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
    [Abstract] [Full Text] [Related]

  • 2. Hemokinin-1 stimulates prostaglandin E₂ production in human colon through activation of cyclooxygenase-2 and inhibition of 15-hydroxyprostaglandin dehydrogenase.
    Dai L, Perera DS, King DW, Southwell BR, Burcher E, Liu L.
    J Pharmacol Exp Ther; 2012 Jan; 340(1):27-36. PubMed ID: 21957267
    [Abstract] [Full Text] [Related]

  • 3. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.
    Ding Y, Tong M, Liu S, Moscow JA, Tai HH.
    Carcinogenesis; 2005 Jan; 26(1):65-72. PubMed ID: 15358636
    [Abstract] [Full Text] [Related]

  • 4. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.
    Tong M, Ding Y, Tai HH.
    Carcinogenesis; 2006 Nov; 27(11):2170-9. PubMed ID: 16632868
    [Abstract] [Full Text] [Related]

  • 5. Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.
    Dai L, King DW, Perera DS, Lubowski DZ, Burcher E, Liu L.
    Dig Dis Sci; 2015 May; 60(5):1236-46. PubMed ID: 25666316
    [Abstract] [Full Text] [Related]

  • 6. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
    Gironella M, Iovanna JL, Sans M, Gil F, Peñalva M, Closa D, Miquel R, Piqué JM, Panés J.
    Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
    [Abstract] [Full Text] [Related]

  • 7. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
    Siddique I, Hasan F, Khan I.
    Scand J Gastroenterol; 2009 Sep; 44(1):56-64. PubMed ID: 18785066
    [Abstract] [Full Text] [Related]

  • 8. Suppression of 15-hydroxyprostaglandin dehydrogenase messenger RNA concentration, protein expression, and enzymatic activity during human ureteral obstruction.
    Jerde TJ, Mellon WS, Fischer SM, Liebert M, Bjorling DE, Nakada SY.
    J Pharmacol Exp Ther; 2004 Apr; 309(1):398-403. PubMed ID: 14718596
    [Abstract] [Full Text] [Related]

  • 9. Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease.
    Horowitz S, Binion DG, Nelson VM, Kanaa Y, Javadi P, Lazarova Z, Andrekopoulos C, Kalyanaraman B, Otterson MF, Rafiee P.
    Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1323-36. PubMed ID: 17218473
    [Abstract] [Full Text] [Related]

  • 10. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L, Kuiper I, Lamers CB, Verspaget HW.
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase.
    Akazawa A, Sakaida I, Higaki S, Kubo Y, Uchida K, Okita K.
    J Gastroenterol; 2002 Sep; 37(5):345-53. PubMed ID: 12051533
    [Abstract] [Full Text] [Related]

  • 12. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
    Klebl FH, Olsen JE, Jain S, Doe WF.
    J Pathol; 2001 Dec; 195(5):609-15. PubMed ID: 11745698
    [Abstract] [Full Text] [Related]

  • 13. Improvement of real-time polymerase chain reaction for quantifying TNF-alpha mRNA expression in inflamed colorectal mucosa: an approach to optimize procedures for clinical use.
    Cui G, Olsen T, Christiansen I, Vonen B, Florholmen J, Goll R.
    Scand J Clin Lab Invest; 2006 Dec; 66(3):249-59. PubMed ID: 16714253
    [Abstract] [Full Text] [Related]

  • 14. Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene.
    Li M, Xie J, Cheng L, Chang B, Wang Y, Lan X, Zhang D, Yin Y, Cheng N.
    Cancer Invest; 2008 Nov; 26(9):905-12. PubMed ID: 19034772
    [Abstract] [Full Text] [Related]

  • 15. Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.
    Miyaki A, Yang P, Tai HH, Subbaramaiah K, Dannenberg AJ.
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G559-66. PubMed ID: 19608733
    [Abstract] [Full Text] [Related]

  • 16. Glucocorticoids and tumor necrosis factor-alpha synergize to induce absorption by the epithelial sodium channel in the colon.
    Bergann T, Zeissig S, Fromm A, Richter JF, Fromm M, Schulzke JD.
    Gastroenterology; 2009 Mar; 136(3):933-42. PubMed ID: 19185581
    [Abstract] [Full Text] [Related]

  • 17. Role of EP4 receptor and prostaglandin transporter in prostaglandin E2-induced alteration in colonic epithelial barrier integrity.
    Lejeune M, Leung P, Beck PL, Chadee K.
    Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1097-105. PubMed ID: 20813914
    [Abstract] [Full Text] [Related]

  • 18. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease.
    Renner M, Bergmann G, Krebs I, End C, Lyer S, Hilberg F, Helmke B, Gassler N, Autschbach F, Bikker F, Strobel-Freidekind O, Gronert-Sum S, Benner A, Blaich S, Wittig R, Hudler M, Ligtenberg AJ, Madsen J, Holmskov U, Annese V, Latiano A, Schirmacher P, Amerongen AV, D'Amato M, Kioschis P, Hafner M, Poustka A, Mollenhauer J.
    Gastroenterology; 2007 Nov; 133(5):1499-509. PubMed ID: 17983803
    [Abstract] [Full Text] [Related]

  • 19. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease.
    Kruidenier L, Kuiper I, van Duijn W, Marklund SL, van Hogezand RA, Lamers CB, Verspaget HW.
    J Pathol; 2003 Sep; 201(1):7-16. PubMed ID: 12950012
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
    Tsiolakidou G, Koutroubakis IE, Tzardi M, Kouroumalis EA.
    Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.